Detalhe da pesquisa
1.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694649
2.
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Leuk Lymphoma
; 65(4): 460-471, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164812
3.
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation.
J Blood Med
; 11: 123-130, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32308515
4.
Treatment of very high-risk classical Hodgkin Lymphoma: cases' selection from real life and critical review of the literature.
Acta Biomed
; 91(S-5): 13-22, 2020 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525130
5.
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study.
J Craniomaxillofac Surg
; 47(8): 1203-1208, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929994
6.
The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study.
PLoS One
; 10(2): e0114856, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25658605
7.
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy.
Leuk Lymphoma
; 60(11): 2806-2809, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31057013
8.
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
Leuk Lymphoma
; 54(5): 1020-7, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035648
9.
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.
J Clin Oncol
; 29(7): 814-24, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21189387
10.
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
PLoS One
; 5(8): e12162, 2010 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20730046
11.
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Blood
; 100(5): 1559-65, 2002 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12176870